Citadel Advisors’s FT Vest US Equity Enhance & Moderate Buffer ETF March XMAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$799K Buy
+19,724
New +$793K ﹤0.01% 8186
2025
Q2
Sell
-6,190
Closed -$227K 15405
2025
Q1
$227K Sell
6,190
-12,542
-67% -$459K ﹤0.01% 10198
2024
Q4
$678K Buy
18,732
+5,062
+37% +$182K ﹤0.01% 7895
2024
Q3
$485K Buy
13,670
+1,967
+17% +$68.7K ﹤0.01% 8323
2024
Q2
$405K Buy
+11,703
New +$396K ﹤0.01% 8493
2023
Q4
Sell
-46,207
Closed -$1.46M 15386
2023
Q3
$1.46M Buy
46,207
+38,983
+540% +$1.23M ﹤0.01% 5822
2023
Q2
$227K Buy
+7,224
New +$222K ﹤0.01% 9607

Other funds holding XMAR

Citadel Advisors's XMAR Position: Q1 2026 in Review

Citadel Advisors opened a new position in FT Vest US Equity Enhance & Moderate Buffer ETF March (XMAR) in Q1 2026: 19,724 shares worth $799K. The stake represents ﹤0.01% of the portfolio and ranks #8186 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in XMAR as recently as Q1 2025.

Citadel Advisors first reported a position in XMAR in Q2 2023 and has held it in 7 quarters since. The position peaked at $1.46M in Q3 2023. 69 funds tracked by Wall St. Rank hold XMAR as of Q1 2026.

  • Citadel Advisors held 19,724 shares of FT Vest US Equity Enhance & Moderate Buffer ETF March worth $799K as of Q1 2026.
  • FT Vest US Equity Enhance & Moderate Buffer ETF March was a new Citadel Advisors position in Q1 2026.
  • FT Vest US Equity Enhance & Moderate Buffer ETF March made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #8186 holding.
  • Citadel Advisors first reported a position in FT Vest US Equity Enhance & Moderate Buffer ETF March in Q2 2023 and has held it in 7 quarters since.
  • Citadel Advisors's FT Vest US Equity Enhance & Moderate Buffer ETF March position peaked at $1.46M in Q3 2023.
  • 69 funds tracked by Wall St. Rank held FT Vest US Equity Enhance & Moderate Buffer ETF March as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.